Header cover image

Israeli (TA) Clinical Research and Equipment Industry Analysis

UpdatedNov 13, 2024
DataAggregated Company Financials
Companies1
  • 7D0.8%
  • 3M13.4%
  • 1Y-15.7%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 2.3%, driven by gains from every company within the industry. In the past year, the industry is down 16%.

Industry Valuation and Performance

Has the Israeli Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 13 Nov 2024₪21.8m₪198.0k-₪6,157,000.00n/a-3.5x109.9x
Fri, 11 Oct 2024₪20.8m₪198.0k-₪6,157,000.00n/a-3.4x105.1x
Sun, 08 Sep 2024₪21.1m₪198.0k-₪6,157,000.00n/a-3.4x106.6x
Tue, 06 Aug 2024₪18.7m₪118.0k-₪26,020,000.00n/a-0.7x158.1x
Thu, 04 Jul 2024₪22.0m₪118.0k-₪26,020,000.00n/a-0.8x186.8x
Sat, 01 Jun 2024₪20.8m₪118.0k-₪26,020,000.00n/a-0.8x175.9x
Mon, 29 Apr 2024₪15.8m₪118.0k-₪26,020,000.00n/a-0.6x133.6x
Wed, 27 Mar 2024₪20.9m₪91,000.00-₪29,137,000.00n/a-0.7x229.5x
Fri, 23 Feb 2024₪22.0m₪91,000.00-₪29,137,000.00n/a-0.8x242.3x
Sun, 21 Jan 2024₪22.7m₪91,000.00-₪29,137,000.00n/a-0.8x249.2x
Tue, 19 Dec 2023₪23.3m₪91,000.00-₪29,137,000.00n/a-0.8x255.8x
Thu, 16 Nov 2023₪25.4m₪91,000.00-₪29,137,000.00n/a-0.9x279.6x
Sat, 14 Oct 2023₪25.9m₪91,000.00-₪29,137,000.00n/a-0.9x284.8x
Mon, 11 Sep 2023₪27.2m₪91,000.00-₪29,137,000.00n/a-0.9x298.4x
Wed, 09 Aug 2023₪30.6m₪73,000.00-₪10,040,000.00n/a-3.1x419.6x
Fri, 07 Jul 2023₪30.4m₪73,000.00-₪10,040,000.00n/a-3x416.4x
Sun, 04 Jun 2023₪26.9m₪63,000.00-₪7,847,000.00n/a-3.4x427.2x
Tue, 02 May 2023₪31.7m₪63,000.00-₪7,847,000.00n/a-4x503.1x
Thu, 30 Mar 2023₪31.1m₪7,000.00-₪5,370,000.00n/a-5.8x4449.5x
Sat, 25 Feb 2023₪32.7m₪7,000.00-₪5,370,000.00n/a-6.1x4675.5x
Mon, 23 Jan 2023₪33.7m₪7,000.00-₪5,370,000.00n/a-6.3x4820.1x
Wed, 21 Dec 2022₪34.6m₪7,000.00-₪5,370,000.00n/a-6.4x4936.7x
Fri, 18 Nov 2022₪44.7m₪7,000.00-₪5,370,000.00n/a-8.3x6389.3x
Sun, 16 Oct 2022₪46.4m₪7,000.00-₪5,370,000.00n/a-8.6x6630.9x
Tue, 13 Sep 2022₪45.6m₪3,000.00₪382.0k119.3x119.2x15183.4x
Thu, 11 Aug 2022₪45.5m₪3,000.00₪382.0k119.2x119.2x15181.8x
Sat, 09 Jul 2022₪41.8m₪3,000.00₪382.0k109.5x109.5x13941.6x
Mon, 06 Jun 2022₪45.8m₪3,000.00₪382.0k120x120x15274.6x
Wed, 04 May 2022₪46.1m₪3,000.00₪382.0k120.6x120.6x15350.5x
Fri, 01 Apr 2022₪49.7m₪3,000.00₪382.0k130x130x16551.2x
Sun, 27 Feb 2022₪47.1m₪15,000.00-₪1,352,000.00n/a-34.9x3143.1x
Tue, 25 Jan 2022₪48.7m₪15,000.00-₪1,352,000.00n/a-36x3243.4x
Thu, 23 Dec 2021₪53.5m₪15,000.00-₪1,352,000.00n/a-39.6x3568.6x
Sat, 20 Nov 2021₪58.0m₪15,000.00-₪1,352,000.00n/a-42.9x3866.5x
Price to Earnings Ratio

-42.9x


Total Market Cap: ₪58.0mTotal Earnings: -₪1,352,000.00Total Revenue: ₪15,000.00Total Market Cap vs Earnings and Revenue0%0%0%
Israeli Clinical Research and Equipment Industry Price to Earnings3Y Average 12.1x202220232024
Current Industry PE
    There is only one company in the Israeli Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 136% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Israeli Clinical Research and Equipment compare with similar industries?

IL Market3.17%
Healthcare0.44%
Life Sciences0.78%
Clinical Research and Equipment0.78%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BOLT BioLight Life Sciences₪4.670.8%
+₪167.7k
-15.7%PS109.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BOLT

₪4.67

BioLight Life Sciences

7D

0.8%

1Y

-15.7%